Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI may help predict heart risk in elderly surgery patients

NCT ID NCT07566013

Knowledge-focused Sponsor: DİLEK KALAYCI Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a computer model can predict heart injury after major orthopedic surgery in patients 65 and older. Researchers will combine blood tests, frailty scores, and other health data to build a machine learning tool. The goal is to help doctors spot high-risk patients before surgery, but this is an observational study and does not test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a tool that helps doctors identify elderly patients at high risk of heart injury before surgery, allowing for better planning and care.
What could go wrong
This is an observational study, not a treatment trial. The model may not work perfectly in all hospitals or patient groups, and it does not directly improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of geriatric patients (aged 65 years) undergoing major orthopedic surgery and requiring postoperative intensive care unit follow-up. Eligible participants must have at least one cardiac troponin level measured within the first 72 hours postoperatively. Patients on chronic dialysis due to end-stage renal disease and those with insufficient preoperative laboratory data will be excluded. The population is selected to represent high-risk geriatric patients in a tertiary training and research hospital setting

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All patients aged 65 years and older. * Patients undergoing major orthopedic surgery (hip fracture repair, total knee/hip arthroplasty, and revision surgeries). * Patients operated on within the designated study period (January 2021 - December 2023). * Patients with complete access to preoperative clinical data (comorbidities, medication use) and baseline laboratory parameters (Hemoglobin, Creatinine, Albumin). * Patients who had at least one postoperative cardiac troponin (hs-cTn) measurement within the first 72 hours after surgery. Exclusion Criteria: * Patients with a documented history of acute myocardial infarction or elevated baseline troponin levels in the preoperative period (to differentiate acute injury from surgical causes). * Patients with end-stage renal disease (ESRD) requiring dialysis (as chronic kidney dysfunction persistently elevates baseline troponin levels). * Patients with missing critical preoperative data or incomplete postoperative troponin follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty hip fracture myocardial ischemia Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty Geriatric patients Hip surgeries Myocardial ischemia Postoperative complications

Contacts and locations

Locations

  • Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

    Ankara, Ankara, 06630, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.